The first genetic test for prostate cancer which causes the death of about 10,000 British men every year.
The new test which is called PCA3, willed be unveiled this week by an American company called Gen-Probe, which will market the product with the assistance of leading cancer campaigners and experts.
It searches for a gene in the urine, which if positive indicates the man has prostate cancer.
Injecting Botox into enlarged prostates reduces their size,so researchers in Portugal have concluded.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment